Drug-nutrient cocrystallization-driven strategy towards self-assembly of milrinone and ferulic acid provides an exemplification in perfecting in vitro/vivo characteristics of anti-heart failure drugs

Lu Liu,Yue-Ming Yu,Yu Yu,Fan-Zhi Bu,Zhi-Yong Wu,Cui-Wei Yan,Yan-Tuan Li,Yueming Yu
DOI: https://doi.org/10.1039/d2nj01509a
IF: 3.3
2022-05-04
New Journal of Chemistry
Abstract:A drug-nutrient cocrystallization-driven strategy has been established to highlight the superiority of nutraceutical ferulic acid (FEA) in perfecting the biopharmaceutical peculiarities of anti-heart failure drug milrinone (MLN). Taking the strategy as guidance, a novel cocrystal of MLN with FEA, namely MLN-FEA, is assembled and characterized, which reveals that the obtained solid form is a cocrystal of MLN molecule and FEA with the ratio of 1:1. There are milrinone-ferulic acid hydrogen-bonding couples and are assembled to hydrogen-bonding chains in the crystal, these chains connect the bilayer structure of MLN molecules gathering with π···π interactions of C=O/CN groups with the pyridine rings to the whole three-dimensional framework. The combination of theory and experiment approaches prove that the aggregation motifs and structural features constituted by the introduction of ferulic acid in the crystal lattice have significant effect on improving the solubility and permeability of the cocrystal. Interestingly, compared with the parent drug MLN, the ameliorated properties in vitro can be effectively transformed into pharmacokinetic trait in vivo, revealing the extended half-life and raised bioavailability. Thereby, the current research not only supplies a novel solid form of MLN with potential commercial value, but provides some new opinions for the applications of nutritionals in cardiotonic pharmaceutical cocrystals.
chemistry, multidisciplinary
What problem does this paper attempt to address?